| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J0491 |
Injection, anifrolumab-fnia, 1 mg |
90 |
72 |
$142K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
3,186 |
2,016 |
$121K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
1,175 |
944 |
$89K |
| Q5121 |
Injection, infliximab-axxq, biosimilar, (avsola), 10 mg |
75 |
65 |
$67K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
111 |
71 |
$66K |
| J3380 |
Injection, vedolizumab, intravenous, 1 mg |
14 |
12 |
$51K |
| J1745 |
Injection, infliximab, excludes biosimilar, 10 mg |
41 |
39 |
$43K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
1,017 |
716 |
$17K |
| J0490 |
Injection, belimumab, 10 mg |
31 |
26 |
$13K |
| 96415 |
|
423 |
340 |
$10K |
| J1756 |
Injection, iron sucrose, 1 mg |
547 |
254 |
$10K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
278 |
213 |
$7K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
455 |
406 |
$4K |
| J2919 |
Injection, methylprednisolone sodium succinate, 5 mg |
200 |
119 |
$1K |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
709 |
479 |
$1K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
12 |
12 |
$625.00 |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
127 |
97 |
$549.37 |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
241 |
170 |
$320.08 |
| J7040 |
Infusion, normal saline solution, sterile (500 ml = 1 unit) |
67 |
37 |
$116.45 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
20 |
12 |
$6.88 |